Vikas Jaitely: How we can fight antibiotic-resistant superbugs with a new class of vaccines

The alarming rise of "superbugs" could claim up to 10 million lives globally by 2050 due to their unique ability to resist antibiotics. However, pharmacist Vikas Jaitely is researching ways we can battle these drug-resistant bacteria — by studying how they evolve in order to create more effective treatments and vaccines.

Episodio siguiente

S2019E14 - Lars Jönsson: "Healthcare Anthem of Merck KGaA, Darmstadt, Germany"